SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-17-005116
Filing Date
2017-05-12
Accepted
2017-05-12 14:13:40
Documents
47
Period of Report
2017-03-31

Document Format Files

Seq Description Document Type Size
1 form10-q.htm 10-Q 306497
2 image_001.jpg GRAPHIC 7993
3 ex31-1.htm EX-31.1 16658
4 ex32-1.htm EX-32.1 7943
  Complete submission text file 0001493152-17-005116.txt   2242193

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE FILE endv-20170331.xml EX-101.INS 327542
6 XBRL SCHEMA FILE endv-20170331.xsd EX-101.SCH 34441
7 XBRL CALCULATION FILE endv-20170331_cal.xml EX-101.CAL 35441
8 XBRL DEFINITION FILE endv-20170331_def.xml EX-101.DEF 129822
9 XBRL LABEL FILE endv-20170331_lab.xml EX-101.LAB 237376
10 XBRL PRESENTATION FILE endv-20170331_pre.xml EX-101.PRE 183202
Mailing Address 6320 CANOGA AVENUE 15TH FLOOR WOODLAND HILLS CA 91367
Business Address 6320 CANOGA AVENUE 15TH FLOOR WOODLAND HILLS CA 91367 (800) 489-4774
ENDONOVO THERAPEUTICS, INC. (Filer) CIK: 0001528172 (see all company filings)

IRS No.: 452552528 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-55453 | Film No.: 17837856
SIC: 2834 Pharmaceutical Preparations